Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dorset Management Corporation is a private investment management firm and family office that serves as the primary investment vehicle for financier Donald Sussman, the founder of Paloma Partners. The firm is a prominent institutional investor within the life sciences, biotechnology, and healthcare sectors, frequently appearing as a significant shareholder in small-to-mid-cap public companies. Dorset Management provides strategic capital to support the clinical development and commercialization of novel therapeutics and medical technologies. Its portfolio has historically included significant positions in companies such as Protalix BioTherapeutics and Aeterna Zentaris. The firm operates with a focus on long-term value creation through strategic equity investments in the healthcare space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dorset Management.